Quality of diabetes care in cancer: a systematic review.
Quality of diabetes care in cancer: a systematic review.
复制标题
DOI：
10.1093/intqhc/mzy124
复制
发表时间：
2019-03-01
期刊：
影响因子：
--
通讯作者：
Bankhead CR
中科院分区：
文献类型：
--
作者：
Griffiths RI;Keating NL;Bankhead CR
忽视癌症期间的其他情况可能会破坏与早期检测和改善癌症治疗相关的成果。我们对癌症中糖尿病护理的质量进行了系统评价。从 1996 年至今，我们对 Medline 和 Embase 进行了系统检索，以确定有关癌症患者糖尿病护理质量的研究。如果研究符合以下标准，则选择研究：纵向或横断面观察研究；人口由糖尿病患者组成；暴露包括任何类型的癌症，结果包括糖尿病护理质量指标，包括医疗就诊、监测和测试、生物参数的控制或糖尿病和其他相关药物的使用。开发了结构化数据收集表格，以提取有关研究设计的信息和四种类型的质量指标：医生就诊、检查或糖尿病教育（统称为“医疗保健就诊”）；监控和测试；生物参数的控制；以及药物的使用和依从性。有来自 5 个国家的 15 项研究。没有一致的证据表明癌症与较少的医疗就诊、较低的生物参数监测和测试或较差的生物参数（包括血糖）控制有关。然而，大量证据表明癌症与糖尿病药物和其他药物（例如抗高血压和降胆固醇药物）依从性较低有关。有证据表明癌症与糖尿病和其他药物的依从性较差有关。进一步的初步研究可以阐明癌症对其他糖尿病质量指标的影响。
Overlooking other conditions during cancer could undermine gains associated with early detection and improved cancer treatment. We conducted a systematic review on the quality of diabetes care in cancer. Systematic searches of Medline and Embase, from 1996 to present, were conducted to identify studies on the quality of diabetes care in patients diagnosed with cancer. Studies were selected if they met the following criteria: longitudinal or cross-sectional observational study; population consisted of diabetes patients; exposure consisted of cancer of any type and outcomes consisted of diabetes quality of care indicators, including healthcare visits, monitoring and testing, control of biologic parameters, or use of diabetes and other related medications. Structured data collection forms were developed to extract information on the study design and four types of quality indicators: physician visits, exams or diabetes education (collectively ‘healthcare visits’); monitoring and testing; control of biologic parameters; and medication use and adherence. There were 15 studies from five countries. There was no consistent evidence that cancer was associated with fewer healthcare visits, lower monitoring and testing of biologic parameters or poorer control of biologic parameters, including glucose. However, the weight of the evidence suggests cancer was associated with lower adherence to diabetes medications and other medications, such as anti-hypertensives and cholesterol-lowering agents. Evidence indicates cancer is associated with poorer adherence to diabetes and other medications. Further primary research could clarify cancer’s impact on other diabetes quality indicators.
登录
查看更多内容
DOI：
10.1093/intqhc/mzx149
发表时间：
2017-12-01
期刊：
International journal for quality in health care : journal of the International Society for Quality in Health Care
影响因子：
--
作者：
Chua WL;See MTA;Legio-Quigley H;Jones D;Tee A;Liaw SY
通讯作者：
Liaw SY
影响因子：
--
作者：
MORRIS, JA;GARDNER, MJ
通讯作者：
GARDNER, MJ
影响因子：
2.5
作者：
Irizarry, Lauren;Li, Qijuan E.;Mckoy, June M.
通讯作者：
Mckoy, June M.
影响因子：
2.6
作者：
Santorelli, Melissa L.;Steinberg, Michael B.;Demissie, Kitaw
通讯作者：
Demissie, Kitaw
影响因子：
3.7
作者：
Shin JY;Shim HY;Jun JK
通讯作者：
Jun JK